Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Community pharmacy witnesses highest dispensing activity in 2021/22, report reveals

Dispensing activity by community pharmacy in England has witnessed a 4.2 per cent increase across the year 2021 till March 2022, the Pharmacy Market Review 2022 report revealed.

The report launched by Christie & Co, said: “All pharmacy settings saw improvements in dispensing numbers, with standard community settings seeing the highest increase of 4.2 per cent, with the average moving to 7,173 items, albeit still below the combined average.”


“The independent sector fared better than corporate pharmacy, with a combined average increase of 3.5 per cent versus a 1.8 per cent increase in corporate dispensing. Despite some improvement, integrated pharmacies remained the lowest at 1.9 per cent, in part due to the continued restrictions on patient access.”

Dispensing activity for England across the year to March 2022 increased by 4.5 per cent to an average of 7,765 items per month, reversing the decline witnessed in 2021.

Resourcing Challenges

Analyzing both valuation and transactional data for 2021/22, Christie & Co found that wages (including locum costs) have risen by 0.2 per cent, wages (excluding locum costs) have risen by 0.5 per cent, locum costs as a percentage of total wage costs have fallen by 2.9 per cent, the EBITDA margin has risen by 1.7 per cent, and Gross Profit margin has risen by 1.9 per cent.

"Resourcing in the sector remains challenging and has placed a huge strain on community pharmacies, as, increasingly, staff are being lured away."

According to data supplied by Locate a Locum to Christie & Co, the average hourly rate as of July 2022 for locum cover across the UK was £37.49, an increase of £4.81 on the 12-month average it recorded in 2021. In England, hourly locum rates increased to circa £36.95, whereas in Wales and Scotland the rates increased to £37.93 and £48.86, respectively.

Online pharmacy platforms

Throughout the UK’s lockdowns, remote dispensing via online platforms, and the benefits that it brought both operators and patients, was invaluable, and dispensing numbers rose as a result. Of a group of seven operators sampled by Christie & Co, all but one showed continued online dispensing item growth, returning a combined average increase of 22 per cent in the 12 months to June 2022.

Total items dispensed by key online pharmacy platform increased by 202 per cent from 2020 to 2021, from 12.1 million to 24.5 million. There was a further 22 per cent increase from 2021 to 2022, taking the total to 29.9 million.

Funding 

Christie Finance highlighted rising pressure from lenders for borrowers to evidence that there is enough ‘proven’ profit to cover any finance loans once they have withdrawn what they need for themselves.

"With a few key funders withdrawing from the pharmacy finance market in 2022, existing lenders are needed to fill this void. With ‘alternative’ and sometimes less experienced lenders, it has been harder for buyers to access the finance they require."

However, there is no shortage of demand for pharmacies. Year to date, Christie Finance has witnessed a 35 per cent increase in instructions, with keen buyers seeking support and guidance.

Tony Evans, Head of Pharmacy at Christie & Co, comments, “As we have emerged from the grips of the pandemic, the sector has continued to deliver its pivotal primary care role. Whilst there have been gains in dispensing volumes, the sector has also had to contend with increasing cost headwinds exemplified in supply and drug pricing issues, as well as staff resourcing issues alongside significant increases in locum costs.

“Nonetheless over the last year, we have witnessed many pharmacy contractors keen to expand their businesses both through acquisition as well as the development of additional services. As a result, the market has continued to see positive activity, something we reported in our Business Outlook 2022 publication. We are pleased to report that this trajectory has continued, mirroring that of the previous year, with appetite across all aspects of the market.”

The report analyzed key trends in the pharmacy sector in 2021 and the first half of 2022; reviewing market composition, operational activity, employment challenges, key dispensing and services activity, online pharmacy platforms, and sector funding. It also includes publicly available data and proprietary data from key business intermediaries, including Locate a Locum.

Christie & Co reported positive market activity, with prices bouncing back from an almost static level in 2020 to a 4.3 per cent increase in 2021, a trajectory that has continued in 2022 across all market areas.

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less